Bowel Research Uk Appoints New Chief Executive Officer

April 30, 2024 11:42 PM PDT | By Pressat
 Bowel Research Uk Appoints New Chief Executive Officer
Image source: Kalkine Media
Wednesday 1 May, 2024

For immediate release: Wednesday 1 May 2024


Bowel Research UK appoints new Chief Executive Officer


Bowel Research UK, which funds research into bowel cancer and other bowel diseases, has appointed Lindsay Easton as its new Chief Executive Officer, who came into post on 1 May 2024.


She takes over from Lynn Dunne, who has been in the role since December 2021. Lynn will retire at the end of June 2024, continuing to work with the charity until then to ensure a smooth transition.


Lindsay will continue to build on the successes of the past two and a half years, working with the Board of Trustees to define the organisational strategy and future direction for Bowel Research UK for the next five years.

Lindsay said: “Almost 43,000 people are diagnosed with bowel cancer every year in the UK and over a million suffer from bowel diseases. Despite this, there are so many neglected areas of research – from understanding the gut microbiome, to improving life for people with a stoma, and using knowledge about inherited bowel conditions to develop new treatments. I’m delighted to join a charity that is dedicated to answering these tough research questions, in areas of science where there is still so much to uncover.”


Lynn said: “It’s been a real privilege to lead Bowel Research UK through a challenging time for the sector. Our small team punches well above its weight, and I’m proud that we’ve delivered successful fundraising campaigns that have funded truly innovative research and supported early career researchers through funding their PhDs.”


Lindsay’s experience spans more than 25 years in the charity sector, including a six-year stint as CEO for Brain Research UK. Her previous senior fundraising and marketing roles included posts at Action for Children, Amnesty International Australia, British Heart Foundation, Young Lives vs Cancer and Diabetes UK.


Asha Senapati, Chair of Bowel Research UK, said: “I’m excited to work with Lindsay to enhance the incredible momentum we’ve built in fundraising recently, nearly doubling the donations we’ve received in two years to be able to fund our cutting-edge research. I’m sure her experience will strengthen our strategy and witness the charity have a growing impact in years to come.”

ENDS

Notes to editors:

About Bowel Research UK

Bowel Research UK is funding life-changing research into bowel cancer and other bowel diseases. Every year over 16,000 people die from bowel cancer in the UK and over a million suffer from bowel disease. By researching cutting edge treatments and investing in the best science, we’re saving and improving people’s lives We’re the UK’s leading specialist bowel cancer and bowel disease research charity and our research is saving and improving lives. https://www.bowelresearchuk.org/





Distributed by https://pressat.co.uk/


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Sponsored Articles


Investing Ideas

Previous Next